TPB — Turning Point Brands, Inc.

Summary of TPB Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Revenue: Increased 29% year-over-year to $121 million.
• Modern Oral Revenue: Contributed $41.3 million, reflecting a 266% increase year-over-year.
• Adjusted EBITDA: Rose 14% to $30 million, with a margin of 24.8%.
• Gross Margin: Held steady at 55.9%.
• SG&A Expenses: Increased to $47.7 million, up $3.1 million sequentially due to investments in Modern Oral and higher freight costs.
• Cash Position: Ended the quarter with $222.8 million in cash and generated free cash flow of $19.2 million.
• CapEx: Reported at $3.3 million for the quarter.

2. Strategic Updates and Business Highlights

• Modern Oral Segment Growth: Significant focus on white nicotine pouch brands (FRE and ALP) with plans for increased investment in marketing and sales.
• Distribution Expansion: ALP is set to expand into brick-and-mortar retail, ahead of schedule, with expectations for significant growth in Q2 2026.
• Sales Force Expansion: On track to double the sales force to enhance market presence.
• Manufacturing Progress: New production lines expected to be qualified soon, aiming to improve domestic production capabilities.
• Stoker's Segment Performance: Net revenue increased 70% to $81 million, driven by both legacy brands and Modern Oral growth.

3. Forward Guidance and Outlook

• 2026 Guidance: Initiating gross revenue guidance for Modern Oral at $220 million to $240 million, with net sales guidance of $180 million to $190 million.
• Q1 2026 EBITDA: Expected to be between $24 million and $27 million, reflecting increased investments in white pouch sales and marketing.
• CapEx for 2026: Projected at $4 million to $5 million, excluding Modern Oral-related projects.

4. Challenges and Points of Concern

• Zig-Zag Segment Decline: Revenue decreased by 13% to $40 million, as anticipated, due to the strategic focus on Modern Oral.
• Margin Pressures: Elevated tariffs impacted Stoker's margins, particularly in the white pouch category.
• Investment Timing Uncertainty: The company noted that investment levels may fluctuate throughout the year based on high ROI opportunities, creating potential unpredictability in financial performance.

5. Notable Q&A Insights

• Sales and Marketing Investments: Management emphasized the need for upfront investments to support the launch of ALP in retail, indicating a commitment to growth despite short-term costs.
• Domestic Production Outlook: Progress on domestic production is expected to enhance margins, but improvements may take time to reflect in financial results.
• Market Growth Drivers: Both existing consumer usage and new user adoption are seen as key growth vectors for the nicotine pouch category.
• Tax Landscape: Management acknowledged potential tax increases on nicotine pouches but noted that these would affect all players equally, maintaining a level competitive playing field.
• Distribution Strategy: There is a strong focus on expanding distribution in both chain and independent retail environments, with an emphasis on optimizing shelf space and product visibility.

Overall, TPB's Q4 2025 results reflect strong growth in the Modern Oral segment, strategic investments for future expansion, and a cautious but optimistic outlook for 2026 amidst some operational challenges.